| Literature DB >> 26458758 |
A V Aleshkin1, E O Rubalskii1, N V Volozhantsev2, V V Verevkin2, E A Svetoch2, I A Kiseleva1, S S Bochkareva3, O Yu Borisova1, A V Popova4, A G Bogun2, S S Afanas'ev3.
Abstract
Traveler's diarrhea (TD) is caused by Escherichia coli in 30% of cases. We have developed a phage cocktail for prophylaxis of TD caused by E.coli, Shigella flexneri, Shigella sonnei, Salmonella enterica, Listeria monocytogenes or Staphylococcus aureus, and investigated its effectiveness against infection caused by the non-pathogenic Lac (-) strain of E.coli K12 C600 in animal and human trials. On the 6th day of both animal and human trials E. coli K12 C600 strain was detected in titer of 104 CFU/g of mice feces and 106 CFU/g of human feces in the control (untreated) groups, while it was not detected in the samples of either of the study (phage-treated) groups. These results have great significance because the original coliphages included in the cocktail have a broad host-range including ETEC, EAEC and EHEC strains which cause severe cases of TD.Entities:
Keywords: EAEC; EHEC; ETEC; phage prophylaxis; phage-based probiotic dietary supplement; traveler's diarrhea
Year: 2015 PMID： 26458758 PMCID： PMC4589986 DOI： 10.1080/21597081.2015.1074329
Source DB: PubMed Journal: Bacteriophage ISSN： 2159-7073